Surveillance and management of dysplasia in patients with inflammatory bowel disease | difficile infection-related outcomes in European participants in the bezlotoxumab MODIFY I and II trials |
---|---|
2019 update of the WSES guidelines for management of Clostridioides Clostridium difficile infection in surgical patients | Antibiotics and probiotics in inflammatory bowel disease: When to use them? The facts about inflammatory bowel diseases |
In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management.
9Feldman M, et al, eds | In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management |
---|---|
World Journal of Emergency Surgery |
National Institute of Diabetes and Digestive and Kidney Diseases.
27